Eosinophilia as a predictor of response to checkpoint inhibition in patients with metastatic melanoma.
Immune checkpoint inhibitors can prolong survival and lead to cure in metastatic melanoma.Baseline indices have not proven clinically useful as predictors of response.Identifying early treatment response would have clinical and ilootpaperie economic benefits.The Christchurch Hospital Oncology Department maintains a prospective registry of melanoma